
Life sciences investment fund concentrating on eye-care and ophthalmic technology opportunities

Private equity firm investing in Chinese enterprises and building long-term partnerships with them

Yonghua Capital is a private equity investor. It concentrates on Chinese enterprises, aiming to raise their value through long-term partnerships and to share the returns with its partners.
Its website names three companies from its portfolio:
Summary written by TrustList from the business's own published information, Oct 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Yonghua Capital.
Similar listings buyers compare against this one.

Life sciences investment fund concentrating on eye-care and ophthalmic technology opportunities

US mezzanine and private equity investor financing privately owned middle-market companies across several industries

Seed and Series A investor in cyber security and business software companies across the United States

Private investment firm with offices in New York and London backing healthcare technology and other companies

Advises and co-manages strategic venture programmes for large corporations

Innovation and venture programmes commercialising research from the Mass General Brigham hospital network

Growth equity investor backing technology companies in the Mid-Atlantic, Southeast and Southwest of the United States

Life sciences venture firm supporting biotech and health companies through private financing and public markets
Everything here links back to the same verified catalogue. Pick your next stop.